RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
100 hedge funds and large institutions have $673M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 49 increasing their positions, 10 reducing their positions, and 5 closing their positions.
500% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 5
390% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 10
90% more capital invested
Capital invested by funds: $355M → $673M (+$319M)
33% more funds holding
Funds holding: 75 → 100 (+25)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less call options, than puts
Call options by funds: $57.2M | Put options by funds: $71.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$16.3M |
| 2 |
BC
Broadfin Capital
New York
|
+$16M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$12.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.28M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$5.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$2.9M |
| 2 |
FM
Forward Management
San Francisco,
California
|
-$1.71M |
| 3 |
AC
Armistice Capital
New York
|
-$1.41M |
| 4 |
ST
Spot Trading
Chicago,
Illinois
|
-$1.16M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$1.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FM
101
Forward Management
San Francisco,
California
| – | -$1.71M | -165,500 | Closed |
|
|
AC
102
Armistice Capital
New York
| – | -$1.41M | -130,000 | Closed |
|
|
103
Allianz Asset Management
Munich,
Germany
| – | -$1.1M | -100,905 | Closed |
|
|
QT
104
Quantbot Technologies
New York
| – | -$8K | -819 | Closed |
|
RPTP Hedge Fund Activity: Q2 2015 in Review
100 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q2 2015, worth a combined $673M — up 90% from $355M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new RPTP positions and 5 closed out — a net gain of 25 holders — while 49 added to existing stakes and 10 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $16.3M. The largest seller was Jane Street, cutting an estimated $2.9M.
- 100 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q2 2015, up from 75 in Q1 2015.
- Funds reported $673M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q2 2015, up 90% quarter-over-quarter.
- 30 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q2 2015 and 5 closed out, a net change of +25 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q2 2015 was D.E. Shaw & Co, an estimated $16.3M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q2 2015 was Jane Street, an estimated $2.9M sold.
Based on aggregated 13F filings for Q2 2015.